Core MRI technology provides most advanced scanners for
highest intraoperative image quality and best workflow
available
MINNEAPOLIS,
July 23, 2014 /PRNewswire/ - IMRIS
Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today
announced that the Company has obtained regulatory CE mark for
integrating the next generation MRI core technology into the
VISIUS® Surgical Theatre allowing for sales and
marketing in the European Union.
This newest imaging technology, based on the Siemens Aera
1.5T(tesla) and Skyra 3.0T MRI scanners, helps IMRIS deliver even
better image quality, faster 3D image acquisition, and improved
ease-of-use and workflow during surgical procedures using
intraoperative MRI (iMRI). The Company received United States Food
and Drug Administration (FDA) approval for these advancements in
February 2014.
"These high-field intraoperative scanner options will give a
hospital's clinical team state-of-the-art applications and image
quality that increase productivity," said IMRIS President and CEO
Jay D. Miller. "We bring the latest
and unequaled imaging technology into the operating room where it
can make the most difference - during the surgery. More and more
neurosurgical centers are using image guidance with VISIUS iMRI for
an expanding list of conditions and procedures and adjunctive
interventions beyond brain tumor resections, such as laser ablation
for tumors and epilepsy using stereotactic tools, deep brain
stimulation (DBS) and other minimally-invasive techniques that are
designed to improve patient outcomes."
Inside a VISIUS Surgical Theatre equipped with high-field iMRI,
surgeons have on-demand access to real-time data and
state-of-the-art imaging during the procedure as the scanner
uniquely moves on ceiling-mounted rails. The Company also designs
and manufactures proprietary intraoperative CTs, head fixation
devices, imaging coils, and OR tables for use in this unique and
multifunctional intraoperative environment.
About IMRIS
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing
image guided therapy solutions through its VISIUS Surgical Theatre
- a revolutionary, multifunctional surgical environment that
provides unmatched intraoperative vision to clinicians to assist in
decision making and enhance precision in treatment. The multi-room
suites incorporate diagnostic quality high-field MR, CT and angio
modalities accessed effortlessly in the operating room setting.
VISIUS Surgical Theatres serve the neurosurgical, spinal,
cardiovascular and cerebrovascular markets and have been selected
by 58 leading medical institutions around the world.
SOURCE IMRIS Inc.
Image with caption: "The IMRIS VISIUS Surgical Theatre with
intraoperative MRI (iMRI) has received CE mark for European
distribution for including Siemens Aera and Skyra MR technology.
This provides neurosurgeons using the system with the most advanced
MR scanners for the highest intraoperative image quality and
workflow in an operating room. (CNW Group/IMRIS Inc.)". Image
available at:
http://photos.newswire.ca/images/download/20140723_C8482_PHOTO_EN_42224.jpg